Government oversight of software used in the health care industry must be flexible in an era of rapid technological advancements, a representative of the American Cancer Society testified on Nov. 19 before the House Energy and Commerce Committee subcommittee on health.

“Any oversight system should be fluid,” said J. Leonard Lichtenfeld, M.D., deputy chief medical officer at the cancer society. “Technology is advancing at a speed that challenges our ability to provide effective oversight. Some of the technology used today was almost unheard of five years ago, so any new oversight structure should not be so rigid that it cannot quickly adapt to new realities.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access